Top

Educational Presentations

Impact of the COVID-19 Pandemic on Psychosis 

The implications of the COVID-19 pandemic will have pervasive effects on schizophrenia and psychosis research and clinical services worldwide. In this webinar, four presenters share research on the impact of the COVID-19 pandemic on psychosis.

Presented By

Gemma Modinos
Institute of Psychiatry, Psychology & Neuroscience, King’s College London | United Kingdom
Chair and Moderator

Ellie Brown
University of Melbourne/Orygen | Australia
The Potential Impact of COVID-19 on Psychosis: A Rapid Review of Contemporary Epidemic and Pandemic ResearchFergus Kane
Maudsley Hospital and Bethlem Royal Hospital | United Kingdom
The Challenge of Equitably Providing Therapy During the COVID-19 Pandemic. Preliminary Data and Thoughts from the PICuP Service

James MacCabe
Institute of Psychiatry, Psychology and Neuroscience, King’s College London | United Kingdom
Clozapine Treatment and Risk of COVID-19

Emily A. Troyer
University of California San Diego Department of Psychiatry Hong Laboratory | United States
Potential Impact of COVID-19 on Psychosis Risk and Symptomatology

SIRS 2019 Meeting Presentations

SIRS 2019 Meeting Presentations

Dror Ben-Zeev” My Smartphone Can Do What ! Mobile Health And The Future Of Mental Healthcare

Kristen Brennand: Modeling The Impact Of Rare And Common Variants In Schizophrenia Using Stem Cells

Deanna Kelly: Schizophrenia And Gluten New Target And Precision Medicine

Steven Leifman: Awards And Keynote Speaker Judge Steven Leifman

Anthony Morrison: Cognitive Behavior Therapy For People With Psychosis

Sohee Park: Schizophrenia In The Flesh, The Case For Behavioral Sciences In The Age Of Big Data

Jessica Turner: International Collaborative Efforts In The Enigma Schizophrenia Working Group


SIRS 2018 Meeting Presentations

SIRS 2018 Meeting Presentations

Graham Blackman: Peripheral Inflammatory Markers are Predictive of Clinical Characteristics and Outcome in Psychosis

William Carpenter: The Near Future for Schizophrenia (Psychosis) Research

Guusje Collin: Abnormal Modular Organization of the Functional Connectome Predicts Conversion to Psychosis in Clinical High-Risk Youth

Vanessa Cropley: Increased Complement Factors C3 and C4 in Schizophrenia and the Early Stages of Psychosis: Implications for Clinical Symptomatology and Cortical Thickness

John Cryan: The Gut Microbiome: A Key Regulator of Neurodevelopment and Behaviour

Melanie Föcking: Proteomic Analysis of Blood-Based Samples From the Optimise (OPtimization of Treatment and Management of Schizophrenia in Europe) Study Point Towards Complement Pathway Protein Changes

John Gilmore: Early Brain and Cognitive Development in Children at Risk for Schizophrenia

Anthony Grace: Stress-Induced Amygdala Hyperactivity Leads to Interneuron Loss and Schizophrenia-Like Pathology in a Developmental Disruption Model of Schizophrenia

Margaret Hahn: Olanzapine Impairs Central Insulin Action: Effects on Body Fuel Preference in Rats

Viktoria Johansson: Cerebrospinal Fluid Findings in Twins with Psychotic Symptoms – Novel Findings and Future Prospects

Kenneth Koblan: SEP-363856, a Candidate Antipsychotic and Antidepressant Compound With a Novel Non-D2 Mechanism of Action

Martin K. Rimvall: Psychotic Experiences are Associated With Health Anxiety and Functional Somatic Symptoms in Pre-Adolescence

André Schmidt: Disorganized Gyrification Network Properties During the Transition to Psychosis

Sara Tomiello: A Computational Trial-By-Trial EEG Analysis of Hierarchical Precision-Weighted Prediction Errors

Daniel Umbricht: Using Imaging and Behavioral Methods Probing Reward Functions as Tools for Decision Making in a Proof-Of-Mechanism Study of the PDE10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

Thomas Weickert: ICAM-1 is Increased in Brain and Peripheral Levels of Soluble ICAM-1 is Related to Cognitive Deficits in Schizophrenia

Dom’s Story

Imagine being a child inflicted with hallucinations and delusions so frightening that you cannot differentiate between our world and a living nightmare.  Welcome to Dom’s world.  Dom was diagnosed with Childhood Schizophrenia at age 10.  This is Dom’s Story.

 

Wordpress Social Share Plugin powered by Ultimatelysocial